[go: up one dir, main page]

SI2278962T1 - Postopki za zdravljenje dermatoloških motenj - Google Patents

Postopki za zdravljenje dermatoloških motenj

Info

Publication number
SI2278962T1
SI2278962T1 SI200930906T SI200930906T SI2278962T1 SI 2278962 T1 SI2278962 T1 SI 2278962T1 SI 200930906 T SI200930906 T SI 200930906T SI 200930906 T SI200930906 T SI 200930906T SI 2278962 T1 SI2278962 T1 SI 2278962T1
Authority
SI
Slovenia
Prior art keywords
treatment
methods
dermatological disorders
dermatological
disorders
Prior art date
Application number
SI200930906T
Other languages
English (en)
Inventor
Magdalena Eisinger
Fa Zhang
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of SI2278962T1 publication Critical patent/SI2278962T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200930906T 2008-02-21 2009-02-20 Postopki za zdravljenje dermatoloških motenj SI2278962T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3025308P 2008-02-21 2008-02-21
PCT/US2009/034684 WO2009105647A1 (en) 2008-02-21 2009-02-20 Methods for the treatment of dermatological disorders
EP09712764.1A EP2278962B1 (en) 2008-02-21 2009-02-20 Methods for the treatment of dermatological disorders

Publications (1)

Publication Number Publication Date
SI2278962T1 true SI2278962T1 (sl) 2014-05-30

Family

ID=40552090

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200930906T SI2278962T1 (sl) 2008-02-21 2009-02-20 Postopki za zdravljenje dermatoloških motenj

Country Status (8)

Country Link
US (2) US8247453B2 (sl)
EP (1) EP2278962B1 (sl)
CY (1) CY1115153T1 (sl)
DK (1) DK2278962T3 (sl)
ES (1) ES2453640T3 (sl)
PT (1) PT2278962E (sl)
SI (1) SI2278962T1 (sl)
WO (1) WO2009105647A1 (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7319107B2 (en) 2001-11-08 2008-01-15 Johnson & Johnson Consumer Companies, Inc. 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
DK2278962T3 (en) 2008-02-21 2014-03-10 Janssen Pharmaceutica Nv Methods for the treatment of dermatological disorders
CA2759730A1 (en) * 2009-04-24 2010-10-28 Janssen Pharmaceuticals, Inc. Stable topical compositions for 1,2,4-thiadiazole derivatives

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD131373A1 (de) 1977-06-17 1978-06-21 Juergen Liebscher Verfahren zur herstellung von 2,3-disubstituierten 5-dialkylamino-1,2,4-thiadiazoliumsalzen
JPS6011481A (ja) 1983-06-30 1985-01-21 Nippon Soda Co Ltd １，２，４−チアジアゾ−ル系誘導体及び農園芸用殺菌剤
JPH02173165A (ja) 1988-12-27 1990-07-04 Nippon Soda Co Ltd 防汚剤
US20020103194A1 (en) 1997-04-30 2002-08-01 Anabella Villalobos Novel muscarinic receptor agonists
EP0805153B1 (en) 1996-04-30 2001-11-14 Pfizer Inc. Novel muscarinic receptor agonists
AU3768799A (en) 1998-04-28 1999-11-16 Trega Biosciences, Inc. Isoquinoline compound melanocortin receptor ligands and methods of using same
EP1076648B1 (de) 1998-04-29 2006-07-12 MERCK PATENT GmbH Verfahren zur katalytischen herstellung von substituierten bipyridylderivaten
US6294534B1 (en) 1998-06-11 2001-09-25 Merck & Co., Inc. Spiropiperidine derivatives as melanocortin receptor agonists
AU742425B2 (en) 1998-06-11 2002-01-03 Merck & Co., Inc. Spiropiperidine derivatives as melanocortin receptor agonists
WO2000024725A1 (en) 1998-10-26 2000-05-04 Vertex Pharmaceuticals Incorporated Pentacyclic compounds useful as inhibitors of hepatitis c virus ns3 helicase
US6348602B1 (en) * 1999-12-23 2002-02-19 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors
WO2001055107A2 (en) 2000-01-28 2001-08-02 Melacure Therapeutics Ab Aromatic amines and amides acting on the melanocortin receptors
US6728804B1 (en) 2000-10-27 2004-04-27 Emware, Inc. Remotely reprogrammable communications adapter for providing access to an electronic device
US7319107B2 (en) 2001-11-08 2008-01-15 Johnson & Johnson Consumer Companies, Inc. 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
BR0214024A (pt) 2001-11-08 2004-12-07 Ortho Mcneil Pharm Inc Derivados de 1,2,4-tiadiazol como moduladores de receptor de melanocortina
US7435429B2 (en) 2002-02-07 2008-10-14 Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
DK2278962T3 (en) 2008-02-21 2014-03-10 Janssen Pharmaceutica Nv Methods for the treatment of dermatological disorders
CA2759730A1 (en) 2009-04-24 2010-10-28 Janssen Pharmaceuticals, Inc. Stable topical compositions for 1,2,4-thiadiazole derivatives

Also Published As

Publication number Publication date
DK2278962T3 (en) 2014-03-10
US20120283330A1 (en) 2012-11-08
WO2009105647A1 (en) 2009-08-27
EP2278962A1 (en) 2011-02-02
US8247453B2 (en) 2012-08-21
EP2278962B1 (en) 2014-02-12
US20090215902A1 (en) 2009-08-27
US8536226B2 (en) 2013-09-17
ES2453640T3 (es) 2014-04-08
CY1115153T1 (el) 2016-12-14
PT2278962E (pt) 2014-04-22

Similar Documents

Publication Publication Date Title
EP2166837A4 (en) DRUG COMBINATION USEFUL FOR THE TREATMENT OF SKIN DISORDERS
ZA201007127B (en) Carboxamide compounds for the treatment of metabolic disorders
IL219914A0 (en) Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
IL253293B (en) Desferrioxamine complexes of metals for the treatment of diseases related to the immune system
ZA201107449B (en) Compounds for the treatment of metabolic disorders
ZA201107446B (en) Compounds for the treatment of metabolic disorders
ZA201005116B (en) 6.7-dialkoxy ouinazoline derivatives useful for treatment of cancer related disorders
GB0904284D0 (en) Compounds for the treatment of metabolic disorders
PL1982178T3 (pl) Sposoby leczenia zaburzeń afektywnych
IL209417A0 (en) 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
ZA201101821B (en) 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin deases
IL207668A0 (en) Beloxepin, its enantiomers, and analogs thereof for the treatment of pain
EP2240192A4 (en) TREATMENT OF DERMATOLOGICAL SUFFERING
IL210558A0 (en) Treatment of anxiety disorders
PT2278962E (pt) Métodos para o tratamento de desordens dermatológicas
IL207906A0 (en) Treatment for ocular-related disorders
EP2240024A4 (en) COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
GB0814043D0 (en) The treatment of skin disorders
WO2011097549A9 (en) Treatment skin disorders
GB0819446D0 (en) Treatment of inflammatory disorders
GB0808623D0 (en) Treatment of keratinizing disorders
AU2008901355A0 (en) Method for the treatment of mental disorders
AU2008900258A0 (en) Method for the treatment of mental disorders
AU2009900341A0 (en) Method for the treatment of mental disorders
AU2009902409A0 (en) Method for the treatment of mental disorders